Ignite Creation Date:
2024-05-06 @ 2:34 PM
Last Modification Date:
2024-10-26 @ 1:33 PM
Study NCT ID:
NCT04351334
Status:
COMPLETED
Last Update Posted:
2023-03-27
First Post:
2020-04-15
Brief Title:
Anaplastic Lymphoma Kinase ALK-Positive Non-small Cell Lung Cancer NSCLC Post-alectinib Treatment Patterns
Sponsor:
Pfizer
Organization:
Pfizer
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-03-27
Start Date Type:
ACTUAL
Primary Completion Date:
2022-11-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-11-01
Completion Date Type:
ACTUAL
First Submit Date:
2020-04-15
First Submit QC Date:
April 15 2020
Study First Post Date:
2020-04-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-16
Last Update Post Date:
2023-03-27
Last Update Post Date Type:
ACTUAL